EUVIMEDOpdag EUVIMED
KommentarOpen access · CC BY 4.0

Comment on “Meta‐Analysis of Cost‐Effectiveness” by Bang and Zhao: Combinability, Joint Modeling, and a Two‐Stage Framework for Cost‐Effectiveness Analysis Synthesis

Gian Luca Di Tanna iD, Niklaus Meier iD, Matthias Schwenkglenks iD

Statistics in Medicine · 2026

DOI: 10.1002/sim.70575 ↗

At a glance

Kommentar in Statistics in Medicine, 2026. Written by Gian Luca Di Tanna and 2 co-authors. Institution: University of Applied Sciences and Arts of Southern Switzerland - SUPSI, Lugano, Switzerland. Major MEDLINE topics: Cost-Effectiveness Analysis, Meta-Analysis as Topic, Models, Statistical. Cited 2 times so far (Crossref); 6 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Bang and Zhao address an important methodological gap by proposing meta‐analytic methods for cost‐effectiveness analysis (CEA) based on separate pooling of incremental costs (ΔC) and incremental effectiveness (ΔE), with summaries displayed on the cost‐effectiveness plane. We share the aim of expanding the toolkit for CEA synthesis; however, we believe that several issues need clarification before the proposal can serve as a general blueprint. First, the two motivating examples appear not to satisfy the key combinability criteria described by Shields and Elvidge. Second, the proposal does not incorporate the data harmonization steps recommended for the meta‐analysis of economic evaluations by Bagepally et al. Third, separate univariate pooling does not retain the within‐study association between ΔC and ΔE, which complicates the joint interpretation of the pooled ICER and its uncertainty. As a possible way forward, we propose a two‐stage framework in which a structured combinability assessment and data harmonization precede any quantitative synthesis, and discuss why joint modeling of (ΔC, ΔE) is preferable to separate univariate pooling. In our view, such a framework provides a more defensible route to pooled ICERs, joint uncertainty summaries, and decision‐relevant quantities such as cost‐effectiveness acceptability curves (CEACs).

Subjects

MeSH terms (MEDLINE)

Cost-Effectiveness AnalysisMeta-Analysis as TopicModels, StatisticalHumans

Author keywords

combinabilitycost‐effectiveness analysisdata harmonizationincremental cost‐effectiveness ratiometa‐analysissystematic review of economic evaluation

Authors and institutions

  • University of Applied Sciences and Arts of Southern Switzerland - SUPSI, Lugano, Switzerland.
  • Institute of Health Economics and Health Policy, Bern University of Applied Sciences, Bern, Switzerland.
  • Health Economics Facility, Department of Public Health, University of Basel, Basel, Switzerland.

ORCID profiles: Gian Luca Di Tanna, Niklaus Meier, Matthias Schwenkglenks

Cite

APA

Di Tanna, G. L., Meier, N., & Schwenkglenks, M. (2026). Comment on “Meta‐Analysis of Cost‐Effectiveness” by Bang and Zhao: Combinability, Joint Modeling, and a Two‐Stage Framework for Cost‐Effectiveness Analysis Synthesis. Statistics in Medicine. https://doi.org/10.1002/sim.70575

Vancouver

Di Tanna GL, Meier N, Schwenkglenks M. Comment on “Meta‐Analysis of Cost‐Effectiveness” by Bang and Zhao: Combinability, Joint Modeling, and a Two‐Stage Framework for Cost‐Effectiveness Analysis Synthesis. Statistics in Medicine. 2026. doi:10.1002/sim.70575

BibTeX
@article{DiTanna2026,
  author = {Di Tanna, Gian Luca and Meier, Niklaus and Schwenkglenks, Matthias},
  title = {Comment on “Meta‐Analysis of Cost‐Effectiveness” by Bang and Zhao: Combinability, Joint Modeling, and a Two‐Stage Framework for Cost‐Effectiveness Analysis Synthesis},
  journal = {Statistics in Medicine},
  year = {2026},
  doi = {10.1002/sim.70575}
}
Start for free →